RECRUITINGINTERVENTIONAL

Digital Therapy in Self-management of COPD Patients

Digital Therapy in Self-management of Chronic Obstructive Pulmonary Disease Patients：A Prospective, Open-labled, Multicenter Randomized Controlled Clinical Study.

About This Trial

This project adopts a whole-process digital therapy intervention package composed of an inhalation technique assessment device, an electronic inhalant medication monitoring device and digital software to guide patients use the inhaler correctly personalizedly, record and manage the behavior data of chronic obstructive pulmonary disease (COPD) patients during the use of inhalant medication, and provide personalized reminders and feedback to patients according to the data. The purpose is to analyze whether this digital intervention scheme can reduce the number of acute exacerbations of COPD, improve the management effect of COPD, and reduce the burden of disease by improving the medication compliance of COPD patients.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Patients diagnosed with COPD 2. Aged 40 and above 3. Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks 4. Can operate a smartphone proficiently 5. Take inhalation medication suits for the inhalation monitoring device as treatment 6. Fully understand and be willing to sign the willing to sign a consent form form Who Should NOT Join This Trial: 1. Certain comorbidities (e.g. unstable coronary complications) 2. Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months 3. Pregnant or lactating women 4. ABS allergy history Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: 1. Patients diagnosed with COPD 2. Aged 40 and above 3. Had one or more severe acute exacerbations in the past year, and be in stable condition for the last 4 weeks 4. Can operate a smartphone proficiently 5. Take inhalation medication suits for the inhalation monitoring device as treatment 6. Fully understand and be willing to sign the informed consent form Exclusion Criteria: 1. Certain comorbidities (e.g. unstable coronary complications) 2. Undergone thoracic, abdominal or ophthalmic surgery in recent 3 months 3. Pregnant or lactating women 4. ABS allergy history

Treatments Being Tested

BEHAVIORAL

Full process digital therapy intervention package

Patients will receive individualized inhalation skills guidance after being tested by inhalation capacity measuring device, and be equipped with electronic inhalation monitoring devices, which can record their medication using data, reminding patients to use the medication on time, and correct their inhalation mistake. They can also check their inhalation record on their mobile phones. Clinicians can check the record every month to assess their adherence.

Locations (1)

China Japan Friendship Hospital

Beijing, Beijing Municipality, China